Skip to main navigation Skip to search Skip to main content

Measurable Residual Disease Before Reduced-Intensity Allogeneic Transplantation in Patients With Myeloid Malignancy

  • Gege Gui
  • , Laura W. Dillon
  • , Christopher S. Hourigan

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)2413-2415
Number of pages3
JournalJournal of Clinical Oncology
Volume39
Issue number21
DOIs
StatePublished - Jul 20 2021
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this